Rights on Expiration. The licenses granted in Articles 2.1 and 2.3 become effective on the Effective Date, shall continue as royalty-bearing rights, on a Licensed Product-by-Licensed Product and Licensed Service-by-Licensed Service and country-by country basis until the expiration of the Running Royalty obligation in accordance with Article 3.3 with respect to such Licensed Product or Licensed Process in such country, unless this Agreement is sooner terminated according to its terms, and following such expiration, shall become, fully paid-up with respect to such Licensed Product or Licensed Service in such country. Such fully-paid up licenses shall survive any expiration or termination of this Agreement.
Rights on Expiration. At the end of the initial term hereof, the Master Licensee may renew the franchise rights granted hereunder for consecutive terms of ten years each if the Master Licensee: a. At least thirty days prior to expiration of the term, executes the then current form of Master License Agreement; provided, however, the terms of the Master License Agreement shall be no less favorable than those terms and conditions then being offered to third parties; b. Has complied with all provisions of this Agreement during the initial term. “Compliance” shall mean, at a minimum, that the Master Licensee has not received written notification from the Licensor of a material breach hereunder more than five times during the term hereof; c. Executes a general release covering all claims the Master Licensee may have against the Licensor in connection with the completion of the then applicable term of this Agreement; and d. Pays a successor Master License fee as designated in the Addendum attached hereto. 13.3.
Rights on Expiration. At the end of the initial term hereof, the Master Licensee may renew the franchise rights granted hereunder for consecutive terms of ten years each if the Master Licensee:
Rights on Expiration. Upon the expiration, but not an earlier termination, of this Agreement with respect to a particular country in relation to a particular Product, Partner will have a fully paid-up, non-exclusive license, which includes the right to sublicense, under the Licensed Technology and Optimer’s share in Joint Patents to Develop, use, promote, market, sell, offer for sale, import, export and otherwise commercialize such Product within the Field in such country. For clarity, Partner shall retain ownership of all MAA Approvals on expiration of this Agreement.
Rights on Expiration. At the end of the initial term hereof, the Master Franchisee shall have the option to renew the franchise rights granted hereunder for consecutive terms of fifteen (15) years each if the Master Franchisee:
Rights on Expiration. After the date royalties are no longer payable on any Licensed Product in a country, Novo Nordisk shall have a fully paid-up, irrevocable, non-exclusive license under the Licensed Intellectual Property to research, develop, make, have made, manufacture, [**] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Exhibit 10.1 use, import, export, distribute, sell, offer for sale and otherwise transfer Licensed Products in the country. Upon the date royalties are no longer payable in all countries and for all Licensed Products, Novo Nordisk shall have a fully paid-up irrevocable, worldwide, non-exclusive license for all Licensed Products.
Rights on Expiration. Upon expiration of this Agreement in its entirety (but not its earlier termination), ISLT shall retain the rights to the Trademark in the Territory. BHV shall retain the exclusive license to the Trademark(s) outside the Territory. BHV shall thereafter refrain from using the Trademark or any other trademark confusingly similar thereto for any products in any countries of the Territory.
Rights on Expiration. After expiration in a country, Novo Nordisk shall have a fully paid-up, irrevocable, non-exclusive license under the Licensed Intellectual Property to research, develop, make, have made, manufacture, use, import, export, distribute, sell, offer for sale and otherwise transfer Licensed Products in the country. Upon expiration in all countries and for all Licensed Products, Novo Nordisk shall have a fully paid-up irrevocable, worldwide, non-exclusive license for all Licensed Products.
Rights on Expiration. Upon the expiration, but not an earlier termination, of this Agreement with respect to a particular Collaboration Product:
Rights on Expiration
